IGI INC
10-Q, EX-27.1, 2000-08-11
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: IGI INC, 10-Q, 2000-08-11
Next: IGI INC, 10-Q, EX-27.2, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                             443
<SECURITIES>                                         0
<RECEIVABLES>                                    7,132
<ALLOWANCES>                                       431
<INVENTORY>                                      9,905
<CURRENT-ASSETS>                                19,631
<PP&E>                                          21,896
<DEPRECIATION>                                (12,038)
<TOTAL-ASSETS>                                  37,144
<CURRENT-LIABILITIES>                           21,289
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           103
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                    37,144
<SALES>                                         15,354
<TOTAL-REVENUES>                                16,865
<CGS>                                            9,287
<TOTAL-COSTS>                                    7,375
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,335
<INCOME-PRETAX>                                (1,132)
<INCOME-TAX>                                       596
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (536)
<EPS-BASIC>                                      (.05)
<EPS-DILUTED>                                    (.05)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission